drugset / Trial / NCT00763438
Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to permit the patients with schizophrenia who received Sertindole during a previous randomised trial, study 99824, to continue with this treatment.
Timeline
- Start
- 2007-11
- Primary completion
- 2010-07
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sertindole | Small molecule | — | — |